Cargando…
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is common. Spontaneous remission of disease occurs commonly, nonetheless, over 50% of patients will require treatment and up...
Autores principales: | Obi, Ogugua Ndili, Saketkoo, Lesley Ann, Russell, Anne-Marie, Baughman, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596775/ https://www.ncbi.nlm.nih.gov/pubmed/36314034 http://dx.doi.org/10.3389/fmed.2022.991783 |
Ejemplares similares
-
Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity
por: Obi, Ogugua Ndili
Publicado: (2023) -
Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023) -
Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017) -
HISTOPLASMOSIS IN PATIENT WITH SARCOIDOSIS
por: Wooten, William, et al.
Publicado: (2020) -
Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis
por: Saketkoo, Lesley Ann, et al.
Publicado: (2018)